Navigation Links
LifeNet Health and Salvin Dental Specialties Announce Partnership
Date:6/17/2010

VIRGINIA BEACH, Va., June 17 /PRNewswire/ -- Salvin Dental Specialties, Inc. and LifeNet Health are pleased to announce they have signed an exclusive agreement  to advance LifeNet Health's OraGraft™ allograft products in the dental market.

The two companies have been in partnership since 1995. The new agreement builds on the existing relationship between these two companies, which provides LifeNet Health with Salvin Dental's strong, nationally recognized marketing and sales resources, while LifeNet Health's industry-leading reputation and quality allograft products offer a great bone grafting solution for Salvin Dental customers. LifeNet Health will continue to provide educational and research support to the dental community as well as continual support to its current clients through direct distribution.

Salvin Dental was founded in 1981 and is a global leader in the dental implant industry for bone grafting, instrumentation, and equipment. LifeNet Health, founded in 1982, is the country's largest, independent, non-profit, full-service tissue bank.

Under the agreement, Salvin Dental will act as the exclusive U.S. representative for the promotion of OraGraft™ allograft tissue products in the dental industry along with LifeNet Health. Salvin Dental will increase awareness in the dental industry about the availability of allograft products, which may be particularly beneficial for implant bone grafting and sinus lift procedures.

LifeNet Health is responsible for allograft procurement, processing, and distribution. The company utilizes the latest research and processing techniques to assure the highest quality donor screening and follows strict standards regarding donor qualification, tissue processing, and quality system review. Since introducing Allowash® technology in 1995, LifeNet Health has distributed more than 2.4 million allograft products without incidence of disease transmission.  

Bob Salvin, Founder and CEO for Salvin Dental, said, "Because of LifeNet Health's world-class reputation for its stringent quality processes and Salvin Dental's understanding of the bone grafting needs of the dental industry, this partnership benefits the customers we serve."

Rony Thomas, LifeNet Health's President and CEO, stated, "We are committed to working with Salvin Dental to provide LifeNet Health's OraGraft™ allograft to the patients who need them, and we are proud to be a part of the comprehensive Salvin Dental product offering."

Salvin Dental Specialties, Inc. is dedicated to providing innovative products and exceeding customers' expectations for quality, value, and service every time they call. For additional information about Salvin Dental Specialties, Inc., visit www.salvin.com.

LifeNet Health helps save lives and restore health for thousands of patients each year. LifeNet Health is the world's most trusted provider of transplant solutions, from organ procurement to new innovations in bio-implant technologies and cellular therapies—a leader in the field of regenerative medicine while always honoring the donors and healthcare professionals that allow the healing process.  For additional information about LifeNet Health, visit www.lifenethealth.org.


'/>"/>
SOURCE LifeNet Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LifeNet Health Announces First Bio-Implant with New Preservation Technology
2. New Publications Highlight LifeNet Healths Life Saving Work in Neurosurgery
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
5. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Tone Deafness Explained, from the Harvard Health Letter
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
10. ViroPharma to Present at Three Upcoming Healthcare Conferences
11. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... "Company") (NASDAQ: UNIS ; ASX: UNS), a developer and ... for the second quarter of fiscal 2016 (three months ended December ... Financial Results for the Second Quarter of Fiscal 2016 ... the second quarter of fiscal 2016 was $4.5 million, compared to ... customers for the second quarter of fiscal 2016 were $17.8 million, ...
(Date:2/9/2016)... QGEN ; Frankfurt Prime ... Genomics to develop and promote comprehensive solutions for ... --> QGEN ; Frankfurt Prime Standard: QIA) ... develop and promote comprehensive solutions for next-generation sequencing ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ...
(Date:2/9/2016)... , February 9, 2016 Amarantus ... focused on developing products for Regenerative Medicine, Neurology and ... featured presenting company at Source Capital Group,s 2016 Disruptive ... 10-11, 2016 in New York City ... February 10, 2016 at 12:30 pm by Gerald ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... The ... 26th: Amateur & Professional Divisions - Time: 7:00pm – 10:00pm | Ticket ... Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: http://www.facebook.com/uspolesportsfederation , ...
(Date:2/10/2016)... DC (PRWEB) , ... February 10, 2016 , ... Anxiety ... level since the start of Medicare Part D a decade ago, according to ... comments from older adults on how they are coping with rapidly rising costs. ...
(Date:2/10/2016)... ... February 09, 2016 , ... According to a recent article ... the number of patients under the age of 30. According to Southern California based ... offices, and may indicate an overall shift in the rapidly growing social acceptance of ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... Medicaid beneficiaries who are diagnosed with autism spectrum disorder (ASD). Beginning Jan. 1, ... treatment using applied behavior analysis (ABA) is key to providing effective treatment for ...
(Date:2/9/2016)... MA (PRWEB) , ... February 09, 2016 , ... ... (WCRI) compares the workers’ compensation fee schedule rates and Medicare rates for a ... services covered in the report, Evaluation of the 2015 Fee Schedule Rates ...
Breaking Medicine News(10 mins):